Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin
The therapeutic use of single-chain antibodies (VHHs) is limited by their short half-life in the circulation. Here the authors engineer mouse and human red blood cells to express VHHs against botulinum neurotoxin A (BoNT/A) on their surface and show that an infusion of these cells into mice confers...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cc5b7658df0d48e1aa16746d22081aea |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|